Showing results (441-450 of 476) with videos related to

Sort By:
Pageof 48
Allergy, Asthma & Immunology Research|December 4, 2025
High-Dimensional Profiling of Circulating Dendritic Cells and Monocytes in Atopic Dermatitis Patients by Mass CytometrySoyoung Jeong, Kyung Jae Lee, Brian H Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host diseaseSeok Lee, Byung-Sik Cho, Sung-Yong Kim, et al.
Annals of Laboratory Medicine|June 10, 2021
Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial ImmunoassaysSojeong Yun, Ji Hyeong Ryu, Joo Hee Jang, et al.
Leukemia & Lymphoma|October 26, 2011
Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemiaKi-Seong Eom, Hee-Je Kim, Byung-Sik Cho, et al.
Differentiation; Research in Biological Diversity|March 14, 2015
Critical role of Rgs19 in mouse embryonic stem cell proliferation and differentiationYoung Rae Ji, Hei Jung Kim, Si Jun Park, et al.
The New England Journal of Medicine|February 15, 2023
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older AdultsAlberto Papi, Michael G Ison, Joanne M Langley, et al.
International Journal of Hematology|February 19, 2005
Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in KoreaSu-Mi Choi, Dong-Gun Lee, Jung-Hyun Choi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 3, 2017
Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" StudyJae-Ki Choi, Sung-Yeon Cho, Sung-Soo Yoon, et al.
European Journal of Haematology|October 6, 2007
Gemtuzumab ozogamicin in combination with attenuated doses of standard induction chemotherapy can successfully induce complete remission without increasing toxicity in patients with acute myeloid leukemia aged 55 or olderKi-Seong Eom, Hee-Je Kim, Woo-Sung Min, et al.
Lancet (London, England)|February 7, 2021
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trialJohan A Maertens, Galia Rahav, Dong-Gun Lee, et al.
Pageof 48